Welcome to QMI - Proudly supporting Queen Mary University of London
Queen Mary Innovation
Queen Mary Innovation Ltd (QMI) is Queen Mary University of London’s (QMUL) wholly-owned technology transfer company and is responsible for the commercialisation and management of the University’s intellectual property and portfolio of spinout companies.
QMI protects and exploits QMUL’s research-derived intellectual property and helps to maximise the economic and societal impact of that research.
Maximising Economic & Societal Impact
Commercial licenses obtained
Active spin out companies
Innovation disclosures evaluated
QMI supports and manages QMUL’s equity interests in its spinout portfolios. The portfolio currently sits at 12 companies:
QMUL’s Mile End Campus
For initial queries, please contact Lessia Djakowska, Office Manager or fill in the contact form
020 7882 5391
Milestone successfully delivered: 3rd Street Diagnostics and QMUL Licence agreement – Development of a diagnostic test for the early detection of pancreatic cancer
QMUL spin out receives investment to develop energy-saving optical communications technology A Queen Mary University of London (QMUL) spin out company has received investment to commercialise a new material technology which would both drastically cut...
Post-Doctoral Innovator Award 2017 Following last year’s success, Queen Mary Innovation (QMI), together with the London School of Medicine and Dentistry (SMD) and CiTI (Centre for Inflammation and Therapeutic Innovation) is launching the POST-DOCTORAL...
QMUL and Barts Health : Innovation Day and Awards • Pitch Your Idea Awards Competition• Postdoctoral Innovator Awards• Launch of Joint QMUL & Barts Health Crowdfunding Platform• Speakers - Life Science & Healthcare Entrepreneurs• Reception 2...
BioMoti, Pharmidex and Queen Mary University of London secure £662,222 Biomedical Catalyst award BioMoti, Pharmidex and Queen Mary University of London (QMUL) have been awarded a grant of £662,222 by the UK’s innovation agency, Innovate UK. The grant...